Cancer combination therapy comprising AZD2171 and imatinib

Details for Australian Patent Application No. 2005288736 (hide)

Owner AstraZeneca AB

Inventors Wedge, Stephen Robert

Agent Davies Collison Cave

Pub. Number AU-B-2005288736

PCT Pub. Number WO2006/035203

Priority 0506725.1 01.04.05 GB; 0421436.7 27.09.04 GB

Filing date 23 September 2005

Wipo publication date 6 April 2006

Acceptance publication date 14 August 2008

International Classifications

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

29 March 2007 PCT application entered the National Phase

  PCT publication WO2006/035203 Priority application(s): WO2006/035203

14 August 2008 Application Accepted

  Published as AU-B-2005288736

11 December 2008 Standard Patent Sealed

21 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005288737-Combination comprising ZD6474 and imatinib

2005288732-Frequency modulated continuous wave (FMCW) radar having improved frequency sweep linearity